TX Austin의 비만 임상 시험
비만 관련 연구 20개가 Austin 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
피험자 모집 중2상
- Elligo Clinical Research Center /ID# 282166, Austin
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
피험자 모집 중3상
- Texas Diabetes & Endocrinology, Austin
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
피험자 모집 중3상
- Dell Children's Medical Center - PIN, Austin
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
피험자 모집 중2상
- IMA Clinical Research Austin, Austin
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
피험자 모집 중3상
- FutureSearch Trials of Neurology, Austin
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
피험자 모집 중3상
- Austin Heart, Austin
- Velocity Clinical Research - Austin, Austin
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
피험자 모집 중3상
- IMA Clinical Research Austin, Austin
Semaglutide for Post-Smoking Cessation Weight Management
피험자 모집 중2상건강한 지원자 환영
- The University of Texas at Austin, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
피험자 모집 중3상
- AURORA-1 Clinical Site, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
피험자 모집 중3상
- AURORA-2 Clinical Site, Austin
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
피험자 모집 중3상
- Austin Heart, Austin
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
피험자 모집 중3상건강한 지원자 환영
- ACCOMPLISH-2 Research Site, Austin
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
피험자 모집 중2상
- IMA Clinical Research Austin, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
피험자 모집 중3상
- Elligo Clinical Research Center, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
피험자 모집 중3상
- Elligo Clinical Research Center, Austin
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
피험자 모집 중3상
- Austin Heart, Austin
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
피험자 모집 중3상
- ACCOMPLISH-1 Research Site, Austin
- ACCOMPLISH-1 Research Site, Austin
Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
피험자 모집 중1상
- Elligo Clin Res Centre, Austin
A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets
피험자 모집 중1상
- Corxel Investigational Site, Austin
Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)
피험자 모집 중건강한 지원자 환영
- Dell Pediatric Research Center, Austin
- University of Texas at Austin, Austin
다른 도시의 비만 시험
- Houston, TX연구 44개
- Chicago, IL연구 42개
- New York City, NY연구 40개
- San Antonio, TX연구 39개
- Washington, DC연구 33개
- Dallas, TX연구 31개
- Boston, MA연구 29개
- Orlando, FL연구 29개
- Las Vegas, NV연구 27개
- Miami, FL연구 27개
- Baltimore, MD연구 25개
- Jacksonville, FL연구 25개
Austin의 다른 연구
- 비소세포폐암연구 30개
- 암 (전체)연구 21개
- 전이성 암연구 19개
- 대장직장암연구 19개
- 심부전연구 18개
- 과체중연구 18개
- 유방암연구 18개
- 난소암연구 17개
- 자궁내막암연구 16개
- 우울증연구 15개
- 전립선암연구 15개
- 삼중음성 유방암연구 13개
ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.